| content | ||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
4-Acetoxy-DET
|
|
| Systematic (IUPAC) name | |
| 3-(2-Diethylamino-ethyl)-1H-indol-4-yl acetate | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C16H22N2O2 |
| Mol. mass | 273.36 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
4-Acetoxy-DET or 4-Acetoxy-N,N-diethyltryptamine, also known as ethacetin, ethylacybin or 4-AcO-DET is a hallucinogenic tryptamine. It was first synthesized in 1958 by Albert Hofmann in the Sandoz lab.1
Within the body a percentage may be partially hydrolized into the free phenol 4-HO-DET. Human studies concerning the metabolic fate of this drug are lacking.
Contents |
Dosage
4-Acetoxy-DET is orally active, and dosages of 10-25 mg are common. Effects last 4-6 hours.2 The free base is also active when smoked in a dose range of 5-20 mg.1 Smoking 4-acetoxy-DET greatly speeds up the onset; peak effects are experienced within 10 minutes, and are usually over within 1 hour.specify
Legality
4-Acetoxy-DET is unscheduled in the United States, but possession and sales of 4-Acetoxy-DET could be prosecuted under the Federal Analog Act because of its structural similarities to DET.
References
- ^ a b Erowid 4-Acetoxy-DET Vaults : Primer. Accessed on April 19, 2007.
- ^ Tikhal: The Chemistry Continues by Alexander and Ann Shulgin. #16. 4-HO-DET. Accessed on April 19, 2007.
External links
- Erowid 4-Acetoxy-DET vault
- (Swedish) Classification document by the Swedish Institute of Health regarding 4-Acetoxy-DET
|
|||||
